ストックスクリーナーアプリを入手
1.43
1.42%
0.02
前日終値:
$1.41
開ける：
$1.43
24時間の取引高:
49,402
Relative Volume:
0.23
時価総額：
$53.65M
収益：
$25.21M
当期純損益:
$-87.87M
株価収益率:
-0.6067
EPS:
-2.357
ネットキャッシュフロー:
$-89.47M
1週間 パフォーマンス:
+5.93%
1か月 パフォーマンス:
+5.15%
6か月 パフォーマンス:
-35.59%
1年 パフォーマンス:
-1.04%
1日の値動き範囲:
$1.3901
$1.45
1週間の範囲:
$1.33
$1.45
52週間の値動き範囲:
$1.25
$3.95
Metagenomi Therapeutics Inc Stock (MGX) Company Profile
名前
Metagenomi Therapeutics Inc
セクター
電話
(510) 871-4880
住所
5959 HORTON STREET, EMERYVILLE
Compare MGX vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MGX
Metagenomi Therapeutics Inc
|
1.425 | 53.08M | 25.21M | -87.87M | -89.47M | -2.357 |
VRTX
Vertex Pharmaceuticals Inc
|
425.82 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
717.96 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
805.41 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
303.00 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
314.50 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Metagenomi Therapeutics Inc Stock (MGX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-05-07 | 開始されました | H.C. Wainwright | Buy |
| 2024-05-02 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2024-03-05 | 開始されました | BMO Capital Markets | Outperform |
| 2024-03-05 | 開始されました | Chardan Capital Markets | Buy |
| 2024-03-05 | 開始されました | JP Morgan | Overweight |
| 2024-03-05 | 開始されました | Jefferies | Buy |
| 2024-03-05 | 開始されました | TD Cowen | Outperform |
| 2024-03-05 | 開始されました | Wells Fargo | Overweight |
すべてを表示
Metagenomi Therapeutics Inc (MGX) 最新ニュース
Hemophilia Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - GlobeNewswire Inc.
SEC Form DEF 14A filed by Metagenomi Therapeutics Inc. - Quantisnow
[DEF 14A] Metagenomi Therapeutics, Inc. Definitive Proxy Statement - Stock Titan
MGX Price Today: Metagenomi Therapeutics, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
MGX Stock Price, Quote & Chart | METAGENOMI THERAPEUTICS INC (NASDAQ:MGX) - ChartMill
Metagenomi Therapeutics (MGX) Stock: Sentiment Analysis (Weakens) 2026-04-22Large Cap Trends - UBND thành phố Hải Phòng
MGX Financials: Income Statement, Balance Sheet & Cash Flow | Metagenomi Therapeutics, Inc - Stock Titan
A smaller gene editor cut Atxn2 protein 64% in mice, Metagenomi says - Stock Titan
Did Metagenomi Therapeutics, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - Eastern Progress
What is the valuation of Metagenomi Therapeutics (MGX) Stock | Price at $1.39, Up 0.72%Portfolio Management - UBND thành phố Hải Phòng
[Form 4] Metagenomi Therapeutics, Inc. Insider Trading Activity - Stock Titan
MGX: Metagenomi Therapeutics, Inc.Detailed Earnings Estimates - Zacks Investment Research
Metagenomi Can’t Ax IPO Investor Suit Over Moderna Partnership - Bloomberg Law News
If You Invested $1,000 in Metagenomi Therapeutics, Inc (MGX) - Stock Titan
Metagenomi Therapeutics Fiscal Results: Q4 Loss of $22.5M, Annual Loss $87.9MNews and Statistics - IndexBox
Metagenomi Therapeutics (MGX) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance
Metagenomi Therapeutics: Q4 Earnings Snapshot - kens5.com
Metagenomi Therapeutics Reports Business Updates and Full Year 2025 Financial Results - Bitget
Metagenomi Therapeutics Q4 Earnings Assessment - Benzinga
MGX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
MGX Technical Analysis & Stock Price Forecast - Intellectia AI
Metagenomi Therapeutics, Inc. to Present at the 46th Annual TD Cowen Healthcare Conference - The Manila Times
Metagenomi Therapeutics, Inc. CEO Jian Irish to Speak at 46th Annual TD Cowen Healthcare Conference - Quiver Quantitative
Gene-editing firm Metagenomi CEO in TD Cowen fireside chat - Stock Titan
MGXMetagenomi Therapeutics, Inc Latest Stock News & Market Updates - Stock Titan
Is Metagenomi Therapeutics (NASDAQ:MGX) In A Good Position To Deliver On Growth Plans? - Yahoo Finance
Head to Head Analysis: Acusphere (OTCMKTS:ACUS) and Metagenomi (NASDAQ:MGX) - Defense World
Xeris Biopharma (NASDAQ:XERS) and Metagenomi (NASDAQ:MGX) Critical Comparison - Defense World
Metagenomi (NASDAQ:MGX) and UCB (OTCMKTS:UCBJY) Critical Survey - Defense World
These two noteworthy penny stocks can do wonders! Here's more insights into Alto Ingredients, Metagenomi and others - MSN
Aug Sentiment: Why Metagenomi Inc stock could benefit from AI revolutionAnalyst Upgrade & Daily Volume Surge Trade Alerts - moha.gov.vn
Resistance Check: Should I add Metagenomi Inc stock to my portfolioJuly 2025 Catalysts & Reliable Volume Spike Trade Alerts - baoquankhu1.vn
Metagenomi changes name, advances hemophilia A gene therapy program By Investing.com - Investing.com Nigeria
Metagenomi advances gene editing therapies into 2025 - MSN
Metagenomi changes name, advances hemophilia A gene therapy program - Investing.com
Metagenomi Therapeutics Rebrands to Emphasize Therapeutic Focus - TipRanks
Metagenomi to submit IND in Q4 2026 to advance MGX-001 into first human studies - TipRanks
Metagenomi Announces Corporate Name Change to Metagenomi Therapeutics, Inc. and Highlights Recent Business Milestones and 2026 Corporate Outlook - The Manila Times
Metagenomi Announces Corporate Name Change to Metagenomi Therapeutics, Inc. and Highlights ... - bdtonline.com
Gainers Report: Is Metagenomi Inc stock dividend yield sustainableFed Meeting & Weekly Top Performers Watchlists - moha.gov.vn
Is Metagenomi Inc. stock dividend yield sustainableWide Width Options & HOKA model picks for your routine - ulpravda.ru
Operating cash flow per share of Metagenomi, Inc. – NASDAQ:MGX - TradingView — Track All Markets
VIX Spike: Is Metagenomi Inc. stock dividend yield sustainableTrend Reversal & Expert Curated Trade Setups - Улправда
Patterns Watch: Is Metagenomi Inc. stock undervalued vs historical averages2025 Historical Comparison & Consistent Profit Trading Strategies - Улправда
Is Metagenomi Inc. stock positioned well for digital economy2025 Stock Rankings & AI Forecasted Entry and Exit Points - Улправда
Is Metagenomi Inc. stock a defensive play in 2025Earnings Miss & Weekly High Momentum Picks - Улправда
Will Metagenomi Inc. stock attract ESG investors2025 Short Interest & Free AI Powered Buy and Sell Recommendations - Улправда
How interest rate cuts could boost Metagenomi Inc. stock2025 Trading Volume Trends & High Accuracy Investment Entry Signals - ulpravda.ru
Market Overview: Is Metagenomi Inc. stock supported by innovation pipelineWeekly Profit Summary & Expert-Curated Trade Recommendations - ulpravda.ru
Is Metagenomi Inc. stock in correction or buying zoneWeekly Investment Report & Capital Efficiency Focused Ideas - Улправда
Oklahoma City NewsThe OklahomanMetagenomi, Inc.Common Stock (Nasdaq:MGX) Detailed Stock Data - FinancialContent
Metagenomi Therapeutics Inc (MGX) 財務データ
収益
当期純利益
現金流量
EPS
0.78%
3.01%
大文字化:
|
ボリューム (24 時間):